Cargando…
HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models
Human T-cell leukemia virus type 1 (HTLV-1) is the causative infectious agent of adult T-cell leukemia/lymphoma (ATL) and chronic neurological disease. The disparity between silenced sense transcription versus constitutively active antisense (Hbz) transcription from the integrated provirus is not fu...
Autores principales: | Maksimova, Victoria, Smith, Susan, Seth, Jaideep, Phelps, Cameron, Niewiesk, Stefan, Satou, Yorifumi, Green, Patrick L., Panfil, Amanda R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359075/ https://www.ncbi.nlm.nih.gov/pubmed/35958554 http://dx.doi.org/10.3389/fimmu.2022.954077 |
Ejemplares similares
-
HTLV-1 Hbz protein, but not hbz mRNA secondary structure, is critical for viral persistence and disease development
por: Maksimova, Victoria, et al.
Publicado: (2023) -
HTLV-1 CTCF-binding site is dispensable for in vitro immortalization and persistent infection in vivo
por: Martinez, Michael P., et al.
Publicado: (2019) -
The PRMT5 inhibitor EPZ015666 is effective against HTLV-1-transformed T-cell lines in vitro and in vivo
por: Ernzen, Kyle, et al.
Publicado: (2023) -
HTLV-1 persistence and leukemogenesis: A game of hide-and-seek with the host immune system
por: Tan, Benjy J. Y., et al.
Publicado: (2022) -
Functional comparison of the HTLV-1 and HTLV-2 antisense viral proteins: implications for pathogenesis
por: Panfil, Amanda R, et al.
Publicado: (2015)